MDL Sought for Peripheral Neuropathy Lawsuits Over Levaquin, Avelox, Cipro, Other Antibiotics

With a growing number of people filing product liability lawsuits after suffering permanent peripheral neuropathy from Levaquin, Avelox, Cipro or other similar antibiotics, the U.S. Judicial Panel on Multidistrict Litigation (JPML) has been asked to establish centralized proceedings in the federal court system. 

In a motion to transfer (PDF) filed on May 19, a group of plaintiffs ask that all Levaquin lawsuits, Avelox lawsuits, Cipro lawsuits, or other similar claims involving nerve damage following use of a fluoroquinolone antibiotic, be transferred to one judge as part of a multidistrict litigation, or MDL.

There are currently at least 24 cases pending in 16 different federal district courts involving similar allegations that manufacturers of the popular antibiotics failed to adequately warn consumers or the medical community about the risk of permanent and long term peripheral neuropathy problems following use of the drugs.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

Peripheral neuropathy involves damage to the nerves that may impair sensation, movement and other aspects of health. This may leave users with persistent pain, burning, tingling, numbness, weakness and sensitivity to light touches, temperature and motion in the arms and legs, as well as other problems that cause a major disruption to daily activities.

As lawyers continue to review and file additional peripheral neuropathy lawsuits for former users of these antibiotics, it is ultimately expected that hundreds, if not thousands, of similar complaints will be filed in courts throughout the U.S.

Plaintiffs argue that centralizing the litigation before one judge will reduce duplicative discovery into common issues, avoid conflicting pretrial rulings from different judges and serve the convenience of the parties, witnesses and the courts. The motion calls for the cases to be consolidated before U.S. District Judge David R. Herndon in the Southern District of Illinois, who has previously presided over the Yaz litigation and Pradaxa litigation.

Permanent Peripheral Neuropathy Side Effects

Levaquin, Avelox and Cipro are among the most widely used antibiotics in the United States, which are all part of the same class of drugs, known as fluoroquinolones.

In August 2013, the FDA required the makers of all fluoroquinolones to provide stronger warnings about the peripheral neuropathy risk from the antibiotics, indicating problems may last for months or years after an individual stops taking the drug.

Lawsuits allege that prior warnings provided with Levaquin, Avelox, Cipro and other similar drugs misleadingly suggested that reports of peripheral neuropathy among users were rare and that the nerve problems resolve when the medications are no longer used. The new label warnings indicated that the problems could be permanent and urge doctors to consider switching patients to a different class of antibiotics if they experience symptoms of peripheral neuropathy.

The first indication of a possible link between long-term peripheral neuropathy and fluoroquinolone antibiotics came in a study published in 2001, which highlighted reports of 45 patients who suffered persistent peripheral nervous system damage. Plaintiffs maintain that if adequate warnings had been provided about the risk of permanent neuropathy problems, they may have avoided painful and debilitating injuries.

The U.S. JPML is likely to hear oral arguments on the motion at an upcoming hearing session in San Francisco, California that is scheduled for July 30.

Image Credit: |


Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Johnson & Johnson Faces Medical Monitoring Lawsuit Over Future Baby Powder Cancer Risks
Johnson & Johnson Faces Medical Monitoring Lawsuit Over Future Baby Powder Cancer Risks (Posted 2 days ago)

Women who used Johnson's Baby Powder around their genitals for feminine hygiene purposes now live in fear of developing ovarian cancer, according to the class action lawsuit seeking medical monitoring for future diagnoses

More Than 9,600 Join Suboxone Lawsuit Over Tooth Decay in MDL Filing
More Than 9,600 Join Suboxone Lawsuit Over Tooth Decay in MDL Filing (Posted 3 days ago)

A bundled complaint of about 9,600 Suboxone lawsuits were filed in federal court on Friday, ahead of the two-year anniversary of the FDA requiring tooth decay label warnings on the opioid treatment film strips, which is also a deadline for filing a civil complaint in many states.